CoChat

Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis

Open access
Kim, Mi-Rae, Kim, A-Sol, Choi, Hye-In, Jung, Jae-Hun, Park, Ji Yeon, Ko, Hae-Jin · 2020 · PLOS ONE

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

Systemic inflammatory biomarkers have begun to be used in clinical practice to predict prognosis and survival of cancer patients, but the approach remains controversial. We conducted a meta-analysis to determine the predictive value of the c-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and Glasgow prognostic score (GPS)/modified Glasgow prognostic score (mGPS) in the clinical outcome of gastric cancer (GC) patients. We searched literature databases to identify relevant studies. All articles identified in the search were independently reviewed based on predetermined selection criteria. Meta-analysis was conducted to calculate the hazard ratio (HR) and 95% confidence intervals (CI) of overall survival of the included studies. A total of 41 eligible cohort studies, involving a total of 18,348 patients meeting the inclusion criteria, were considered for meta-analysis. Increases in CRP (HR = 1.654, 95% CI: 1.272-2.151), NLR (HR = 1.605, 95% CI: 1.449-1.779), and GPS/mGPS (HR = 1.648, 95% CI: 1.351-2.011) were significantly associated with poorer survival in patients with GC. Substantial heterogeneities were noted in all three markers (I2 = 86.479%, 50.799%, 69.774%, in CRP, NLR, and GPS/mGPS, respectively). Subgroup analysis revealed a significant positive correlation between each marker and poor survival, regardless of country, study quality, cancer stage, study design, or the inclusion of patients undergoing chemotherapy. This meta-analysis demonstrates that CRP, NLR, and GPS/mGPS are associated with poor survival in patients with GC. Further prospective studies using standardized measurements are warranted to conclude the prognostic value of various inflammatory markers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0236445

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Flow diagram of the literature search and selection of studies for the meta-analysis.
Fig 1 Flow diagram of the literature search and selection of studies for the meta-analysis.CC BY · PubMed Central
Fig 2 Forest plots showing results of studies on the association between elevated systemic inflammatory markers (CRP, NLR, GPS/mGPS) and overall survival in GC. Each study is indicated by a point estimate of the hazard ratio (HR) (the size of the square is proportional to the weight of each study) with 95% confidence intervals (CIs). (A) Forest plot of studies evaluating the association between elevated CRP and overall survival (OS) in patients with GC receiving various treatments. (B) Forest plot of studies evaluating the association between the neutrophil-to-lymphocyte ratio (NLR) and OS in GC. (C) Forest plot showing the prognostic effect of GPS/mGPS on the OS of patients with GC.
Fig 2 Forest plots showing results of studies on the association between elevated systemic inflammatory markers (CRP, NLR, GPS/mGPS) and overall survival in GC. Each study is indicated by a point estimate of the hazard ratio (HR) (the size of the square is proportional to the weight of each study) with 95% confidence intervals (CIs). (A) Forest plot of studies evaluating the association between elevated CRP and overall survival (OS) in patients with GC receiving various treatments. (B) Forest plot of studies evaluating the association between the neutrophil-to-lymphocyte ratio (NLR) and OS in GC. (C) Forest plot showing the prognostic effect of GPS/mGPS on the OS of patients with GC.CC BY · PubMed Central
Fig 3 Funnel plots for assessing publication bias for meta-analysis of the correlation between OS and systemic inflammatory markers. (A) CRP, (B) NLR, and (C) GPS/mGPS. Each study is represented by one circle. The vertical line represents the pooled effect estimate.
Fig 3 Funnel plots for assessing publication bias for meta-analysis of the correlation between OS and systemic inflammatory markers. (A) CRP, (B) NLR, and (C) GPS/mGPS. Each study is represented by one circle. The vertical line represents the pooled effect estimate.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Cited by

See all 76

Metadata

Authors
Kim, M.-R., Kim, A.-S., Choi, H.-I., Jung, J.-H., Park, J. Y., & Ko, H.-J.
Affiliations
  • Kyungpook National University Hospital (KR)
  • Kyungpook National University (KR)
Corresponding author
Ko, Hae-Jin
Venue
PLOS ONE
Published
2020-07-27
Volume
15
Issue
7
Pages
e0236445
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3043868076
Cited by
76
References
77
Citations by year
2026: 14 · 2025: 14 · 2024: 17 · 2023: 11 · 2022: 11 · 2021: 8
FWCI
0.80
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Keywords
gastric cancer, inflammatory markers, C-reactive protein, neutrophil-to-lymphocyte ratio, Glasgow Prognostic Score, modified Glasgow Prognostic Score, overall survival, prognostic value, systemic inflammation
MeSH terms
C-Reactive Protein, Humans, Inflammation, Lymphocytes, Neutrophils, Prognosis, Stomach Neoplasms, Biomarkers, Survival Analysis, Publication Bias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0236445
The paper
Kim, M.-R., Kim, A.-S., Choi, H.-I., Jung, J.-H., Park, J. Y., & Ko, H.-J. (2020). Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0236445

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.